The association between patent ductus arteriosus and perinatal infection in a group of low birth weight preterm infants

Iranian Journal of Pediatrics

Volumn 24, Issue 1, 2014, Pages 42-48

  Pistulli, Edmond ^a   Hamiti, Arjan ^a   Buba, Sokol ^b   Hoxha, Alketa ^a   Kelmendi, Nita ^c   Vyshka, Gentian ^a  

^a UNIVERSITY OF TIRANA   (Albania)

^b University Hospital Center 'Mother Teresa'   (Albania)

^c UNIVERSITY OF PRISHTINA   (Serbia)

Author keywords

Intravenous ibuprofen; Oral ibuprofen; Patent ductus arteriosus; Perinatal infection; Prematurity

Indexed keywords

CREATININE; IBUPROFEN; NITROGEN; UREA;

ARTICLE; BLOOD CULTURE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PERINATAL INFECTION; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; UREA NITROGEN BLOOD LEVEL;

EID: 84893210364     PISSN: 20082142     EISSN: 20082150     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Noori S, McCoy M, Friedlich P, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009;123(1):e138-44.
2. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007; 196(2):147e1-147e8.
3. Van Overmeire B, Chemtob S. The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 2005;10(2):177-84.
4. Bersani I, De Carolis MP, Lacerenza S, et al. Is the prophylaxis of patent ductus arteriosus useful in extremely premature infants? Turk J Pediatr 2011; 53(2):187-93.
5. Sekar KC, Corff KE. Treatment of patent ductus arteriosus:indomethacin or ibuprofen? J Perinatol 2008;28(Suppl 1):S60-2.
6. Yang EM, Song ES, Choi YY. Comparison of oral ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus in extremely low birth weight infants. J Pediatr (Rio J) 2013; 89(1):33-9.
7. Gonzalez A, Sosenko IRS, Chandar J, et al. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighting 1000 grams or less. J Pediatr 1996;128(4):474-8.
8. Varsila E, Hallman M, Venge P, et al. Closure of patent ductus arteriosus decreases pulmonary Myeloperoxidase in premature infants with respiratory distress syndrome. Biol Neonate 1995; 67:167-71.
9. Herson VC, Krause PJ, Eisenfeld LI, et al. Indomethacin-associated sepsis in very-low-birth-weight infants. Am J Dis Child 1988;142(5):555-8.
10. Patole SK, Muller R. Enteral feeding of preterm neonates:a survey of Australian neonatologists. J Matern Fetal Neonatal Med 2004;16(5):309-14.
11. Gournay V, Roze JC, Kuster A, et al. Prophylactic ibuprofen versus placebo in very premature infants:a randomized, double-blind, placebo-controlled trial. Lancet 2004;364(9449):1939-44.
12. Richards J, Johnson A, Fox G, et al. A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants. Pediatrics 2009;124(2):e287-93.
13. Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006;(2):CD004213.
14. Cherif A, Jabnoun S, Khrouf N. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. Am J Perinatol 2007;24(6): 339-45.
15. Sangtawesin V, Sangtawesin C, Raksasinborisut C, et al. Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity. J Med Assoc Thai 2006;89(3):314-21.
16. Aly H, Lotfy W, Badrawi N, et al. Oral ibuprofen and ductus arteriosus in premature infants:a randomized pilot study. Am J Perinatol 2007;24(5): 267-70.
17. Patel J, Roberts I, Azzopardi D, et al. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamic in preterm infants with patent ductus arteriosus. Pediatr Res 2000;47(1):36-42.
18. Cherif A, Khrouf N, Jabnoun S, et al. Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics 2008;122(6):e1256-61.
19. Gokmen T, Erdeve O, Altug N, et al. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr 2011;158(4):549-54
20. Erdeve O, Gokmen T, Altug N, et al. Oral versus intravenous ibuprofen:which is better in closure of patent ductus arteriosus? Pediatrics 2009;123(4): e763.
21. Hariprasad P, Sundarrajan V, Srimathy G, et al. Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates. Indian Pediatr 2002;39(1):99-100.
22. Fakhraee SH, Badiee Z, Mojtahedzadeh S, et al. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi 2007;9(5): 399-403.
23. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants:a randomized trial at Ramathibodi Hospital. J Med Assoc Thai 2002;85(Suppl 4):S1252-8.
24. Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai 2003;86(Suppl 3):S563-9.
25. Heyman E, Morag I, Batash D, et al. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns:a pilot study. Pediatrics 2003;112(5):e354.
26. Sasi A, Deorari A. Patent ductus arteriosus in preterm infants. Indian Pediatr 2011;48(4):301-8.
27. Sahn DJ, Allen HD. Real-time cross-sectional echocardiographic imaging and measurement of the patent ductus arteriosus in infants and children. Circulation 1978;58(2):343-54.
28. Roushdy A, Fiky AE, Din DE. Visualization of patent ductus arteriosus using real-time three-dimensional echocardiogram:Comparative study with 2D echocardiogram and angiography. J Saudi Heart Assoc 2012;24(3):177-86.